Chief Medical Officer · NEOGENOMICS INC (NEO)

Lawrence Weiss

A named executive officer of NEOGENOMICS in every fiscal year CompBrief holds from FY2018 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,285,000

Salary $600,000Stock awards $165,000

FY2019: $1,183,674

3rd of 6 named executive officers at Neogenomics by FY2020 total.

7 named officers on file for NEOGENOMICS, FY2020

Lawrence Weiss’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • NEO’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how NEOGENOMICS’s whole pay program stands against its peers

  • NEOGENOMICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NEO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 15, 2021 (DEF 14A).

Free

Get Lawrence Weiss’s full pay file as a PDF — free

More than this page: up to 10 years of Lawrence’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Lawrence Weiss compensation by year

NEOGENOMICS Summary Compensation Table · all 3 fiscal years held
In US dollars, as NEOGENOMICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020
Salary$571,519$600,000$600,000
Bonus$100,000$0$0
Stock awards$0$115,503$165,000
Option awards$152,100$208,171$335,000
Non-equity incentive$32,276$260,000$185,000
Pension and deferred compensation$0$0$0
All other$0$0$0
Total$855,895$1,183,674$1,285,000

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NEOGENOMICS INC DEF 14A filed April 15, 2021, accession 0001193125-21-117812, and prior-year filings. Open the filing on EDGAR.

How this page was built: the NEOGENOMICS INC filed document, accession 0001193125-21-117812. Every figure is read from that document and cited to the page and table it appears in. Filed April 15, 2021.

$856K
$1.2M
$1.3M
FY18
FY19
FY20
SalaryBonusNon-equity incentiveStock awardsOption awards

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU5,824$313,564—
RSU4,420$237,973—
Option6,667—$9.22
Option8,334—$13.87
Option37,514—$28.33
Option27,017—$19.60

Per the Outstanding Equity Awards at Fiscal Year-End table in NEOGENOMICS INC's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

NEOGENOMICS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Douglas VanOortFormer Chair of the Board and Former Chief Executive Officer$4,119,039
Robert ShovlinPresident of Clinical Services$1,297,308
Lawrence Weiss · this pageChief Medical Officer$1,285,000
Douglas BrownChief Strategy and Corporate Development Officer$1,246,154
George CardozaPresident and Chief Operating Officer, Laboratory Operations, Clinical Services$1,189,630
Kathryn McKenzieChief Financial Officer$1,034,616
Sharon ViragChief Financial Officer—

The full NEOGENOMICS compensation record

free company brief

This page is one person within NEOGENOMICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the NEOGENOMICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NEOGENOMICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Lawrence Weiss's compensation dossier · One-time report. No refunds.